Role of molecular chaperones in endocytosis and protein folding diseases
Role of molecular chaperones in endocytosis and protein folding diseases
批准号:
8344744
负责人:
Lois Greene
金额:
$191.37万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AdenovirusesAmyloidAmyloid fibersAuxilinsBindingBiological AssayBiological ModelsCell LineCell membraneCellsCentrosomeClathrinEmbryoEndocytosisEndosomesFibroblastsGoalsKnock-outKnockout MiceLaboratoriesLifeMaintenanceMammalian CellMediatingMolecularMolecular ChaperonesMolecular ConformationMusNeuronsPathway interactionsPharmaceutical PreparationsPhenotypePhosphotransferasesPrionsProcessProtein Structure InitiativeProtein-Folding DiseaseProteinsReportingResearchRoleScrapieSedimentation processSeedsSiteTissuesTransgenesTranslationsWorkYeastscellular imagingcoated pitinterestlight microscopyoverexpressionpreventprion seedsprotein complexrecombinasereconstitutionsup35termination factortraffickingtrans-Golgi Networkyeast prion
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Our laboratory is interested in the formation and dissolution of both normal and pathological protein complexes in the cell with an emphasis on the role of molecular chaperones in these processes. We have continued our studies on the role of Hsc70 in clathrin-mediated endocytosis by generating knockout mice of the HSC70 cochaperones, neuronal-specific auxilin and ubiquitously expressed GAK. Specifically, we wanted to determine the effect of knocking out GAK and also determine the domains of GAK that are essential for its cochaperone function. Using mouse embryonic fibroblasts (MEFs) derived from the conditional GAK knockout mouse, GAK was disrupted by using adenovirus expressing Cre recombinase. Knocking-out GAK, completely blocked clathrin-mediated endocytosis in the MEFs and disrupted the clathrin organization on the plasma membrane and at the trans-Golgi network. Moreover, the GAK-depleted MEFs were arrested at the G1/S checkpoint, but still underwent multiple rounds of centrosome duplication. Interestingly, all of these phenotypes were rescued with a truncated GAK molecule consisting of just the clathrin binding domain and J-domain. Furthermore, this truncated GAK fragment, which was expressed as a transgene, was able to rescue the lethality observed when GAK was knocked out of specific tissues in mice. These results show that the clathrin-binding and J-domains of GAK, but not the kinase and pTen-like domains of GAK, are essential for its cochaperone function.
In addition, we also studied the propagation of prions, infective proteins that can misfold into an amyloid conformation both in mammalian and yeast cells. In mammalian cells, chronically infected scrapie cells, having the misfolded amyloid form of prion, have been shown to be cured by a number of different drugs that have been reported to have different target sites. However, immunostaining of scrapie showed that with all these different anti-prion drugs, the scrapie localized was no longer found cycling throughout the endosomal trafficking pathway, but instead was all localized in lamp-1 positive endosomes. These results indicate that the mechanism by which these drugs clear scrapie is to sequester scrapie in a dead-end compartment, which, in turn, prevents the conversion of the properly folded prion protein to the misfolded amyloid conformation.
Our research on prion has also been extended to yeast, which is a simple model system to study prion propagation. In yeast, the molecular chaperone, Hsp104, regulates the inheritance of several yeast prions including PSI+, which is the prion form of the translation termination factor Sup35p. Both inactivation and overexpression of Hsp104 cures yeast of the PSI plus prion. By using live cell imaging, we have now found that the molecular chaperone, Hsp104, has two activities. It not only severs prion seeds, but also trims or reduces the size of the seeds by removing Sup35 molecules from the end of the amyloid fiber. These released Sup35 molecules do not nucleate new seeds and therefore, trimming does not increase the number of prion seeds. In contrast, severing the does seeds increase the number of new seeds. We have also now found that trimming activity is important for curing of plus prion by overexpression of Hsp104, as well as maintaining the steady-state size of the prion seeds in propagating PSI plus yeast.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of molecular chaperones in protein folding diseases
-
批准号:10699693
-
项目类别:
-
资助金额:$116.56万
-
财政年份:--
-
负责人:Lois Greene
-
依托单位:
Role of molecular chaperones in protein folding diseases
-
批准号:10008749
-
项目类别:
-
资助金额:$114.06万
-
财政年份:--
-
负责人:Lois Greene
-
依托单位:
70-kda Heat Shock Proteins And Their Associated Cofactors
-
批准号:7968966
-
项目类别:
-
资助金额:$156.4万
-
财政年份:--
-
负责人:Lois Greene
-
依托单位:
Role of molecular chaperones in protein folding diseases
-
批准号:10253793
-
项目类别:
-
资助金额:$113.68万
-
财政年份:--
-
负责人:Lois Greene
-
依托单位:
Role of molecular chaperones in endocytosis and protein folding diseases
-
批准号:8557896
-
项目类别:
-
资助金额:$145.63万
-
财政年份:--
-
负责人:Lois Greene
-
依托单位:
70-kda Heat Shock Proteins And Their Associated Cofactors
-
批准号:8149466
-
项目类别:
-
资助金额:$176.19万
-
财政年份:--
-
负责人:Lois Greene
-
依托单位:
Role of molecular chaperones in protein folding diseases
-
批准号:8746541
-
项目类别:
-
资助金额:$139.66万
-
财政年份:--
-
负责人:Lois Greene
-
依托单位:
Role of molecular chaperones in protein folding diseases
-
批准号:9157306
-
项目类别:
-
资助金额:$167.19万
-
财政年份:--
-
负责人:Lois Greene
-
依托单位:
Role of molecular chaperones in protein folding diseases
-
批准号:9353084
-
项目类别:
-
资助金额:$160.17万
-
财政年份:--
-
负责人:Lois Greene
-
依托单位:
Role of molecular chaperones in protein folding diseases
-
批准号:8939752
-
项目类别:
-
资助金额:$139.67万
-
财政年份:--
-
负责人:Lois Greene
-
依托单位:
70-kda Heat Shock Proteins And Their Associated Cofactors
-
批准号:7594363
-
项目类别:
-
资助金额:$224.1万
-
财政年份:--
-
负责人:Lois Greene
-
依托单位:
70-kda Heat Shock Proteins And Their Associated Cofactors
-
批准号:7734941
-
项目类别:
-
资助金额:$171.66万
-
财政年份:--
-
负责人:Lois Greene
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于聚金属氧酸盐对Amyloid蛋白的定点化学修饰及其在阿尔茨海默症治疗中的应用
-
批准号:22077118
-
项目类别:面上项目
-
资助金额:63.0万元
-
批准年份:2020
-
负责人:高楠
-
依托单位:
基于S1P通路探究Amyloid-β在干性年龄相关性黄斑变性中的作用
-
批准号:81870666
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2018
-
负责人:王海燕
-
依托单位:
Amyloid-beta-PirB 相互作用介导小胶质细胞表型和功能变化参与AD进展的机制研究
-
批准号:81601123
-
项目类别:青年科学基金项目
-
资助金额:17.0万元
-
批准年份:2016
-
负责人:都瑾
-
依托单位:
Beta-amyloid寡聚体特有的抗原表位多肽疫苗的研究
-
批准号:30971012
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2009
-
负责人:刘瑞田
-
依托单位:
抗阿兹海默病Beta-Amyloid寡聚物单链可变区抗体的筛选及其动物试验
-
批准号:30570622
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2005
-
负责人:刘瑞田
-
依托单位: